4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-005464
CVP, TAVR sold 620 shares at $81.14 ($50,307)
- CVP, TAVR acquired 620 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lippis Daniel J. · CVP, TAVR
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +620 | $72.68 | $45,062 | 41,030.91 | D |
| 2026-05-18 | Sale : show line 2 in the form 10b5-1 | −620 | $81.14 | $50,307 | 40,410.91 | D |
| Open-market sales · 620 sh · avg $81.14 · $50,307 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-18 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −620 | 6,190 | D |
Loading xslF345X06/doc4.xml…